B01 – Paraneoplastic antigen Ma2 autoantibodies as a blood biomarker for diagnosis, prognosis and detection of early recurrence of small intestine neuroendocrine tumors

Published in 2010 Listed under Basic Science, Poster

Tao Cui, Monica Hurtig , Graciela Elgue, Su-Chen Li, Giuseppe Pelosi, Ahmed Essaghir, Jean-Baptiste Demoulin, Giulia Veronesi, Mohammad Alimohammadi, Kjell Öberg, Valeria Giandomenico

pdf Download Poster (458 KB)

B02 – Changes on Chromosome 18 are Involved in Both Sporadic and Familial Ileal Carcinoid Tumor Development

Published in 2010 Listed under Basic Science

Janet Cunningham, Teresita Diaz de Ståhl Tobias Sjöblom, Gunnar Westin, Jan Dumanski, and Eva Tiensuu Janson Uppsala University, Uppsala. Sweden

B03 – Clinical Utility of Genomic Profiling of Pancreatic Neuroendocrine Tumors

Published in 2010 Listed under Basic Science

Michael J Demeure, MD, MBA, Lisa Evers BSc, Elizabeth Lenkiewicz MSc, Tara Holley BSc, Lukas Bubendorf MD, Christian Ruiz PhD, Kimberly J Bussey, PhD, Michael T. Barrett, PhD

B04 – An Organ Slice Model to Evaluate Carcinoid Tumorogenesis in Liver

Published in 2010 Listed under Basic Science, Poster

Priyodarshan Goswamee, Sasi Arunachalam, Riaz Nasim, Marthe Howard and David R. Giovannucci

pdf Download Poster (2.65 MB)

B05 – Differential Protein Expression in Small Intestinal Carcinoids and Liver Metastases

Published in 2010 Listed under Basic Science, Poster

Michelle Kang Kim, Daguan Wang, Miao Cui, Thomas Curran, Stephen Ward, Richard Warner, Sasan Roayaie, Michail Shafir, Myron Schwartz, David Zhang, Steven Itzkowitz

pdf Download Poster (135 KB)

B06 – Are Primary And Metastatic Tumors The Same?

Published in 2010 Listed under Basic Science

Erika Briann Lindholm, MD; Cathy Anthony, PhD; J. Phillip Boudreaux, MD; Abby Gandolfi, MS; Pam Ryan, RN; Yi-Zarn Wang, DDS MD; Eugene A. Woltering, MD

B07 – Xanthohumol, a novel plant extract, alters neuroendocrine phenotype and inhibits growth of carcinoid cell lines

Published in 2010 Listed under Basic Science, Poster

Catherine M. McManus, BS; Mary Ndiaye BS; Herbert Chen, MD, FACS; Muthusamy Kunnimalaiyaan, PhD

pdf Download Poster (408 KB)

B08 – Methods in the Development of Human Carcinoid Cell Lines

Published in 2010 Listed under Basic Science, Poster

Eric Sceusi, Asif Rashid, Yunfei Zhou, Shaija Samuel, Fan Fan, Ling Xia, Xiang-Cang Ye, Jia Lu, Federico Tozzi, Puja Gaur, Patrick Zweidler-McKay, Raymond Meyn, James Yao, and Lee M. Ellis

pdf Download Poster (8.80 MB)

B09 – Genetic Associations with Sporadic Neuroendocrine Tumor Risk

Published in 2010 Listed under Basic Science, Poster

Monica Ter-Minassian, Zhaoxi Wang, Kofi Asomaning, Michael C. Wu, Chen-Yu Liu, Jessica K. Paulus, Geoffrey Liu, Penelope A. Bradbury, Rihong Zhai, Li Su, Christine S. Frauenhoffer, Susanne M. Hooshmand, Immaculata DeVivo, Xihong Lin, David C. Christiani, Matthew H. Kulke

pdf Download Poster (390 KB)

B10 – Correlation between gene expression profile and tumor behavior of pancreatic neuroendocrine tumors and carcinoids

Published in 2010 Listed under Basic Science, Poster

Yunguang Tong, PhD; Nicholas N. Nissen, MD; Vijay Menon, MD; Edward Wolin, MD; Run Yu, MD, PhD Division of Endocrinology, Department of Surgery, Division of Oncology and Carcinoid and Neuroendocrine Tumor Center, Cedars-Sinai Medical Center, Los Angeles, CA

pdf Download Poster (44 KB)

B11 – Hesperitin, a Potential Therapy for Carcinoid Cancer

Published in 2010 Listed under Basic Science

Barbara Zarebczan MD, Scott N. Pinchot MD, Muthusamy Kunnimalaiyaan PhD, Herbert Chen MD

C01 – Presence of Extra-Hepatic Disease Should Not Preclude Transarterial Chemoembolization for Metastatic Carcinoid

Published in 2010 Listed under Clinical, Poster

Arrese David, Feria-Arias Enrique, Hatzaras Ioannis, Guy Gregory, Khabiri Hooman, Schmidt Carl, Shah Manisha, Bloomston Mark

pdf Download Poster (3.54 MB)

C02 – Short Term Response to Systemic I-131 MIBG Therapy in Metastatic Carcinoid Tumors.

Published in 2010 Listed under Clinical

Richard J Campeau MD, Lowell B Anthony MD, Eugene A Woltering MD, Yi-Zarn Wang MD, and J Phillip Boudreaux MD

C03 – Prognostic Criteria Development for Metastatic Well- or moderately-differentiated Neuroendocrine Tumors

Published in 2010 Listed under Clinical, Poster

Lisa M. Caronia, David Arrese, Lai Wei, Carl R. Schmidt, Daria Arbogast, Mark P. Bloomston, Manisha H. Shah

pdf Download Poster (366 KB)

C04 – Phase I Study of Pasireotide (SOM230) in Combination with Everolimus (RAD001) in Patients with Advanced Neuroendocrine Tumors (NET)

Published in 2010 Listed under Clinical, Poster

Jennifer A. Chan, MD, MPH,; David P. Ryan, MD; Charles S. Fuchs, MD, MPH,; Andrew X. Zhu, MD, PhD; Thomas A. Abrams, MD, Brian M. Wolpin, MD, MPH,; Carolyn Casey, BS; Eileen Regan, RN, BSN, OCN; Kristen Cavanaugh, RN; Matthew H. Kulke, MD, MMSc

pdf Download Poster (112 KB)

C05 – Phase I Study of Sorafenib in Combination with Everolimus (RAD001) in Patients with Advanced Neuroendocrine Tumors (NET)

Published in 2010 Listed under Clinical, Poster

Jennifer A. Chan, MD, MPH,; Robert J. Mayer, MD,; Nadine Jackson, MD, MPH,; Paige Malinowski, BA; Eileen Regan, RN, BSN, OCN; Matthew H. Kulke, MD, MMSc

pdf Download Poster (105 KB)

C06 – Incidental Diagnosis of Pancreatic Neuroendocrine tumors

Published in 2010 Listed under Clinical, Poster

Asima Cheema MD, Jill Weber MPH, Larry Kvols MD, Jonathan Strosberg, MD

pdf Download Poster (60 KB)

C07 – Ki-67 Proliferative Index and the Tumor Grade Predict Progression Free Survival in Ileal Carcinoids

Published in 2010 Listed under Clinical, Poster

Deepti Dhall ,Rugvedita Parakh, Richard Mertens, Girish Dhall, Catherine Bresee, Delma Ines, Fai Chung, Marissa Li, Steven D Colquhoun, Nicholas N Nissen, Run Yu, HanlinWang and Edward Wolin

pdf Download Poster (6.97 MB)

C08 – Evaluation of progression-free survival by blinded independent central review in patients with progressive, well-differentiated pancreatic neuroendocrine tumors treated with sunitinib or placebo

Published in 2010 Listed under Clinical, Poster

Pascal Hammel, Daniel Castellano, Eric Van Cutsem, Patricia Niccoli, Sandrine Faivre, Shem Patyna, Deno Klademenos, Dongrui Ray Lu, Richard Chao, Eric Raymond

pdf Download Poster (385 KB)

C09 – Phase I/II Study of Everolimus (RAD001) in Combination with Temozolomide (TMZ) in Patients with Advanced Pancreatic Neuroendocrine Tumors (NET)

Published in 2010 Listed under Clinical, Poster

Matthew H. Kulke, MD, MMSc,; Lawrence Blaszkowsky, MD; Andrew X. Zhu, MD, PhD; Sarah Florio, BS; Eileen Regan, RN, BSN, OCN; David P. Ryan, MD; Jennifer A. Chan, MD, MPH

pdf Download Poster (110 KB)

C10 – The Efficacy and Safety of Pasireotide (SOM230) in the Treatment of Patients with Metastatic Neuroendocrine Tumors (NET) Refractory or Resistant to Octreotide LAR

Published in 2010 Listed under Clinical, Poster

Larry Kvols, Bertram Wiedenmann, Kjell Öberg, Pharis Mohideen, Thomas M. O’Dorisio, Wouter W. de Herder, Gareth Hughes, Rudolf Arnold, Lowell Anthony

pdf Download Poster (208 KB)

C12 – Surgical Exploration is Superior to All Other Modalities for Locating Primary Carcinoid Tumors

Published in 2010 Listed under Clinical, Poster

Massimino Kristen P., Han Esther, Pommier SuEllen J., Pommier Rodney F

pdf Download Poster (168 KB)

C13 – Small Cell Carcinoma of the Uterine Cervix: A Single-Center Experience

Published in 2010 Listed under Clinical, Poster

Boris G. Naraev, MD, PhD, Michael J. Goodheart, MD, Thomas M. O’Dorisio, MD, Thorvardur R. Halfdanarson, MD

pdf Download Poster (620 KB)

C14 – Evaluation of Chromogranin A and Neuron-specific Enolase as Predictors of Response to Everolimus Therapy in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET)

Published in 2010 Listed under Clinical, Poster

Kjell Öberg, Matthew Kulke, Marianne Pavel, Alexandria Phan, Sakina Hoosen, Jessica St. Peter, Azzeddine Cherfi, and James C. Yao

pdf Download Poster (272 KB)

C15 – Predictors of Lymph Node Sampling and Nodal Metastases in Patients with Pancreatic Neuroendocrine Tumors

Published in 2010 Listed under Clinical

Justin Parekh, MD, Sam C. Wang, MD, Emily K. Bergsland, MD, Alan P. Venook, MD, Robert S. Warren, MD, Grace E. Kim, MD, Eric K. Nakaura, MD, PhD, These authors contributed equally to this work

C19 – Mitotic index and somatostatin receptor status are independent predictors of survival after resection of neuroendocrine tumors metastatic to the liver

Published in 2010 Listed under Clinical

Sasan Roayaie, Paramjeet Singh, Hongfa Zhu, Lihui Qin, Daniel Labow, Michelle Kim, Richard R. P. Warner, Myron Schwartz

C20 – Extensive “Multitasking” Surgery for Advanced Enteropancreatic Neuroendocrine Tumors (NETS): A Safe and Effective Approach

Published in 2010 Listed under Clinical, Poster

Michail Shafir MD, Richard PR Warner MD, Sheilah Gonsalves MD, Jerome J Zacks, MD, Lynn Ratner MD, Michelle Kim MD

pdf Download Poster (4.11 MB)

C21 – Treatment of Pancreatic Neuroendocrine Tumors (pNET) With Everolimus: Improved Progression-Free Survival Compared With Placebo (RADIANT-3)

Published in 2010 Listed under Clinical

Manisha H. Shah, Kjell Öberg, Tetsuhide Ito, Catherine Lombard-Bohas, Edward M. Wolin, Eric Van Cutsem, Carolin Sachs, Robert Winkler, Jeremie Lincy, Timothy Hobday and James C. Yao

C24 – Phase II study of sunitinib malate following hepatic artery embolization for metastatic neuroendocrine tumors

Published in 2010 Listed under Clinical, Poster

Jonathan Strosberg MD, Asima Cheema MD, Tiffany Campos, Tiffany Valone PA, Larry Kvols MD

pdf Download Poster (6.15 MB)

C25 – Prognostic Relevance of a Novel AJCC Staging Classification for Neuroendocrine Tumors of the Pancreas

Published in 2010 Listed under Clinical, Poster

Jonathan Strosberg MD, Asima Cheema MD, Jill Weber MPH, Domenico Coppola MD, Larry Kvols MD

pdf Download Poster (5.41 MB)

C26 – Risk of Metastatic Spread in Patients with Early-Stage, Surgically Resected Pancreatic Neuroendocrine Tumors

Published in 2010 Listed under Clinical, Poster

Jonathan Strosberg MD, Asima Cheema MD, Jill Weber MPH, Domenico Coppola MD, Larry Kvols MD

pdf Download Poster (5.57 MB)

C28 – Survival Analyses of Pancreatic Neuroendocrine Tumors: Contrasting Institutional Databases with Population-based Studies

Published in 2010 Listed under Clinical, Poster

Jonathan Strosberg MD, Thorvardur Halfdanarson MD H. Lee Moffitt Cancer Center, Tampa, Florida, USA ; University of Iowa, Iowa City, Iowa, USA

pdf Download Poster (6.54 MB)

C29 – Expectant Management of the Asymptomatic Primary is Safe in Patients Undergoing Chemoembolization for Metastatic Neuroendocrine Carcinoma

Published in 2010 Listed under Clinical

Tassone, Patrick; Arrese, David; Klemanski, Dori; Shah, Manisha; Schmidt, Carl; and Bloomston, Mark

C30 – Prospective analysis of clinical outcomes and prognostic factors in patients with neuroendocrine tumors (NETs)

Published in 2010 Listed under Clinical, Poster

Monica Ter-Minassian, Jennifer A. Chan, Christine S. Frauenhoffer, Susanne M. Hooshmand, Kofi Asomaning, Xihong Lin, David C. Christiani, Matthew H. Kulke

pdf Download Poster (263 KB)

C31 – Sunitinib for treatment of pancreatic neuroendocrine tumors: Patient-reported outcomes and efficacy across patient subgroups in a Phase III trial

Published in 2010 Listed under Clinical, Poster

Aaron Vinik, Yung-Jue Bang, Jean-Luc Raoul, Juan Valle, Peter Metrakos, Dieter Hörsch, Beata Korytowsky, Rajiv Mundayat, Richard Chao, Eric Raymond

pdf Download Poster (569 KB)

C32 – Radio-guided Exploration Facilitates Surgical Cytoreduction of Neuroendocrine Tumors

Published in 2010 Listed under Clinical, Poster

Yi-Zarn Wang DDS, MD, , Abby E Gandolfi, BS., MS. , Lowell B. Anthony MD, Richard Campeau MD, Eugene Woltering MD. , , and J. Philip Boudreaux MD

pdf Download Poster (101 KB)

C34 – Clinical Effect of Temozolomide in Poorly Differentiated Endocrine Carcinoma (PDEC) after Progression on First-line Chemotherapy

Published in 2010 Listed under Clinical

Staffan Welin MD, PhD, Halfdan SorbyeMD, PhD, Sigrunn Sebjornsen MD, Stian Knappskog, PhD, Christian Busch MD, Kjell Öberg MD,PhD

C35 – RADIANT-2: A Phase III Trial of Everolimus + Octreotide LAR in Patients with Advanced Neuroendocrine Tumors (NET)

Published in 2010 Listed under Clinical

James C. Yao, John D. Hainsworth, Eric Baudin, Marc Peeters, Dieter Hoersch, Lowell Anthony, Judith Klimovsky, Jessica St. Peter, Valentine Jehl, and Marianne Pavel

C36 – Randomized run-in study of Bevacizumab and Everolimus in low- to intermediate- grade neuroendocrine tumors (LGNETs) using perfusion CT (pCT) as functional biomarker

Published in 2010 Listed under Clinical

James C. Yao, Alexandria Phan, Kenneth R. Hess, David Fogelman, Carmen Jacobs, Cecile G. Dagohoy, Colleen C. Leary, Chaan S. Ng

O03 – Open-Label Phase 2 Clinical Trial of LX1606 / LX1032 in Europe: A Novel Agent for Reducing Serotonin Production in Carcinoid Syndrome

Published in 2010 Listed under Other

Phil Brown, Kenny Frazier, Jessica Jackson, Shanna Jackson, Joel Frieman, Brian Zambrowicz

O07 – Tumor and Normal Tissue Uptake of 68Ga-DOTA-tyr3- Octreotide after Treatment with Unlabeled Octreotide in Patients with Carcinoid Tumors and Pancreatic Neuroendocrine Tumors

Published in 2010 Listed under Other

Yusuf Menda, MD, Michael Schultz, PhD, David Bushnell, MD, Thomas O’Dorisio, MD, M. Sue O’Dorisio, MD, PhD